This inventor holds 4 USPTO granted patents. Top assignee: Alberta Research Council Incorporated. Active years: 1996-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-1999
Title: Ulrike Spohr: Innovator in Pharmaceutical Compositions
Introduction
Ulrike Spohr is a prominent inventor based in Boulder, CO (US). She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on kojibioside analogues and disaccharide compounds. With a total of 4 patents to her name, her research has the potential to impact the treatment of inflammation and other health conditions.
Latest Patents
Ulrike's latest patents include the development of modified kojibioside analogues. These novel analogues of kojibiose are designed for use in pharmaceutical compositions. Another significant patent focuses on the administration of valienamine-related disaccharide compounds. This invention aims to reduce inflammation arising from secondary immune responses in mammals due to antigen exposure.
Career Highlights
Ulrike Spohr is associated with the Alberta Research Council Incorporated, where she continues to advance her research and innovations. Her work is characterized by a commitment to improving health outcomes through scientific discovery.
Collaborations
Ulrike has collaborated with notable colleagues, including Om P Srivastava and Roman Szweda. These partnerships have fostered a collaborative environment that enhances the quality and impact of her research.
Conclusion
Ulrike Spohr's contributions to pharmaceutical innovations demonstrate her dedication to advancing medical science. Her patents reflect a commitment to addressing critical health challenges through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile